RxDoctor Payments Data

Loy Bowland, PA

Physician Assistant · Knoxville, TNNPI 1831644905

Payments from drug & device makers

$3,216in general payments, 2019–2025

Across 182 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$713
  • AbbVie$679
  • Lilly USA, LLC$547
  • Novo Nordisk$277
  • Amgen$144
  • GSK$141
  • plus $716 from 13 others

What the payments were for

  • Food & beverage$3,12497%
  • Education$923%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,216 in reported general payments places this provider in the 85th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$93,310
Medicare patients
382
Services billed
2,620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin53$64,967
TrulicityDulaglutide45$54,019
MounjaroTirzepatide33$32,416
FarxigaDapagliflozin Propanediol19$16,652
OzempicSemaglutide14$13,917
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$13,094
RybelsusSemaglutide13$12,008
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,149
JanuviaSitagliptin Phosphate12$6,607
Levothyroxine Sodium134$1,314
Albuterol Sulfate HfaAlbuterol Sulfate53$1,252
Atorvastatin Calcium130$908
Bupropion XlBupropion Hcl19$767
Losartan Potassium91$597
Doxycycline Hyclate68$507

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$547$86,43678 claims
Boehringer IngelheimJardiance$109$64,96753 claims
AstraZenecaFarxiga, Breztri Aerosphere$713$27,80137 claims
Novo NordiskOzempic, Rybelsus$277$25,92527 claims
GSKTrelegy Ellipta$141$13,09420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →